Search

everythinglearnresearchcommunity

for

Search:↓

The 5 mg dose of oral minoxidil is not more effective than the 2.5 mg dose for treating male hair loss.

Social media doesn't significantly influence treatment choices for hair loss, but better education on options is needed.

Targeting multiple pathways may improve treatments for androgenetic alopecia.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Oral minoxidil is as effective as topical minoxidil for male hair loss but has more side effects like excessive hair growth and headaches.

Adipose-derived stem cells may help with hair loss, but more research is needed.

JAK inhibitors do not improve hair regrowth in androgenic alopecia but may prevent further hair loss.

Female pattern baldness may indicate a higher risk of coronary artery disease.

Androgenetic alopecia negatively affects self-esteem and daily stress, especially in young men.

Topical Stemoxydine improves hair density in androgenetic alopecia with few side effects.

GT20029 helps regrow hair in men with hair loss and is well-tolerated.

Young males with severe early-onset hair loss may have a higher risk of metabolic syndrome.

ECM changes may play a role in hair loss, with differences between males and females.

Higher homocysteine levels may inhibit hair growth and are linked to androgenetic alopecia.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Hair loss in Saudi Arabia causes a low psychosocial impact, with less effect on those without a family history of hair loss.

People with non-scarring hair loss often have lower vitamin D levels than those without hair loss.

Androgenetic alopecia negatively affects quality of life, especially in younger, less educated, single, and rural individuals.

Women with androgenic alopecia may have a higher risk of artery problems.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Minoxidil, originally a blood pressure medication, is effective in treating hair loss in men and women, with different strengths recommended for each.

Different types of hair loss need specific treatments, and while many classification systems exist, each has its flaws; more research is needed to refine these systems and treatments.

COVID-19 may cause temporary hair loss in some people.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Mechanical stress contributes to hair loss in androgenetic alopecia.

Androgenetic alopecia requires a personalized treatment plan and psychological support to improve quality of life.

Shorter telomeres in white blood cells may increase the risk of a common type of hair loss.

Metformin is less effective in men with early-onset hair loss.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Androgenetic alopecia significantly affects quality of life, especially for women, who are more willing to pay for treatment.